Recent studies have demonstrated that erythrocytes are a potential component in atheromatous lesions and thrombus formation in patients with ST-elevation myocardial infarction (STEMI). The purpose of this study was to determine the associations of red blood cell (RBC) component of coronary thrombi with oxidative stress and myocardial reperfusion.
Introduction
Atherosclerotic plaque rupture or erosion with thrombosis is a principal mechanism of total vessel occlusion and acute ST-elevation myocardial infarction (STEMI). The mechanism of thrombosis is complex phenomenon that involves the interaction of cellular components, and a coronary thrombus consists mainly of platelets, red blood cells (RBCs), and fibrin and often contains inflammatory cells. Previous studies showed a close association among RBC properties, inflammation, and oxidative stress. 1, 2 It was reported that haeme or haemoglobin released from lysed RBCs can react with peroxides and become a source of free radicals. 1 Moreover, increased production of oxygen-free radicals may change the structural and functional properties of RBCs and increase their aggregability and adhesiveness to the endothelium. 2 Previously, we demonstrated that plasma levels of myeloperoxidase (MPO; a strong pro-oxidant enzyme released from activated neutrophils and monocytes) and oxidized low-density lipoprotein (ox-LDL) are significantly higher in STEMI patients, 3, 4 and that infiltration of MPO-positive neutrophils occurs in coronary culprit lesions with plaque instability. 5 However, the relationships of the RBC component of thrombi with oxidative stress and clinical outcome in STEMI patients remain unknown. The aim of this study was to determine the associations of the RBC component of thrombi with oxidative stress and myocardial reperfusion in STEMI patients treated with thrombus aspiration.
Methods
All patients provided written informed consent, and the Hospital Ethics Committee approved the study.
Study patients
The study included 298 consecutive STEMI patients who had undergone thrombus aspiration during emergent percutaneous coronary intervention (PCI) between July 2002 and June 2006. The inclusion criteria were: symptoms consistent with STEMI lasting .30 min, arrival at our hospital within 12 h of the onset of chest pain, ST-segment elevation .2 mm in ≥2 contiguous precordial leads, and no additional stenosis .50% in the infarct-related artery (IRA). Patients were excluded from the study if they had ≥50% left main coronary artery stenosis, thrombolytic therapy before PCI, variant angina, previous coronary bypass surgery, renal dysfunction (serum creatinine levels ≥2.0 mg/dL), concomitant inflammatory diseases, or malignant tumours. We also excluded patients with electrocardiographic abnormalities that could interfere with ST-segment analysis (left bundle branch block, pacemaker implantation). Additionally, patients were ineligible if no material was obtained or if the aspirated material could not be classified immunohistochemically. Ultimately, 178 patients were enrolled in the study ( Figure 1 ). All patients were taking aspirin and had received 200 mg of ticlopidine or a 300 mg loading dose of clopidogrel before the procedure.
Interventional procedure and angiographic outcomes
The IRA was defined as a major coronary artery perfusing an area compatible with the distribution of ST-segment elevation in the 12-lead electrocardiogram. Patency of the IRA was angiographically assessed before PCI according to the thrombolysis in myocardial infarction (TIMI) flow grade by two independent observers. Baseline intracoronary thrombus was angiographically identified and scored in five degrees according to the TIMI thrombus score. 6 Subsequent PCI was performed for total occlusive lesions or lesions with .75% diameter stenosis (DS), even with TIMI grade 3 flow. After administration of 5000 IU of heparin and conventional wire crossing, thrombus aspiration was performed through the target coronary segment at least ≥2 times until thrombi were angiographically and possibly invisible depending on the operator's judgement. Aspiration was performed using two different thrombectomy devices: the 7-Fr Rescue catheter (Boston Scientific, MN, USA) was used between July 2002 and March 2003; the 7-Fr Thrombuster catheter (Kaneka, Tokyo, Japan) Figure 1 Flowchart of the study.
Erythrocyte-rich thrombus in STEMI was used between April 2003 and Jun 2006. In 14 patients, PercueSurge GuardWire Plus (Medtronic, Santa Rosa, CA, USA), a distal protection catheter, was also used after thrombus aspiration at the operator's discretion. All implanted stents were bare metal stents. Angiographic visible distal embolization was defined as a distal filling defect with abrupt cut-off in the distal vessel of the culprit lesion after PCI. The magnitude of impaired myocardial reperfusion was evaluated by ST-segment resolution (STR) and myocardial blush grade (MBG), assessed as previously reported. 3 Myocardial no-reflow was defined as post-procedural TIMI flow grade ,3, MBG 0/1, and/or STR ,70%. Angiographic restenosis was defined as .50% DS on a follow-up angiogram. Left ventriculography was performed on admission and at 6 months after STEMI, and the left ventricular end-diastolic volume index (LVEDVI) and left ventricular ejection fraction (LVEF) were calculated by the centreline method. The magnitude of LV remodelling was calculated as the percentage increase in the LVEDVI from baseline to 6 months after infarction. Angiographic analysis was performed by two independent cardiologists, who were unaware of the patients' characteristics and histological classifications of aspirated intracoronary thrombi. In cases of disagreement, consensus was reached by further joint reading.
Biochemical analysis
Blood samples were obtained from the forearm using standard vein puncture on admission to the hospital, before heparin administration. Blood samples were collected in a tube containing EDTA, because MPO concentrations in samples collected in EDTA-containing tube were reported to be stable. 7 Collected samples were immediately placed on ice and stored at -808C. Circulating MPO measurement was performed using a sandwich ELISA method as previously reported. 3 Plasma ox-LDL was measured using an anti-ox-LDL monoclonal antibody (DLH3) with separation of the LDL fraction to avoid interference with other plasma constitunents. 4 
Analysis of aspirated samples
The retrieval of the thrombus was done via aspiration through the catheter lumen, and collected from the device filter. Collected thrombi were immediately washed with saline, snap-frozen, and stored at -808C. Frozen samples of aspirated thrombi were serially sectioned to produce 5-mm-thick sections and then fixed in acetone. Every first section was stained with haematoxylin-eosin; the other sections were used for immunohistochemical staining. The immunohistochemical staining and morphometric analysis were shown in the Supplementary material online, file S1.
Statistical analysis
The results for normally distributed continuous variables are expressed as mean + SD, and continuous variables that did not have a normal distribution are presented as median (inter-quartile interval 
Results

Histological findings in aspirated samples
In the 178 patients, only thrombus was found in 127 patients (71%) and both thrombus and plaque fragments were present in 51 patients (29%). Plaque fragments contained macrophage-derived foam cells and occasional smooth muscle cells. Within these thrombi specimens, endothelial cells with microvessel formation, assessed using an antibody against von Willebrand factor, were not detected. In the high-RBC group, most thrombi were stained positive for erythrocytes, and glycoprotein (GP) IIb/IIIa-and P-selectin-positive areas were small ( Figure 2 ). In these thrombi, the erythrocyte-positive area was the inverse of the GP IIb/IIIaand P-selectin-positive areas, and abundant neutrophils and MPOpositive cells were found within the thrombi ( Figure 2E and F ). In the low-RBC group, erythrocyte-positive areas were small, and most thrombi were stained positive for GP IIb/IIIa and P-selectin ( Figure 3 ). In this low-RBC group, there were only a few neutrophils and MPO-positive cells ( Figure 3E and F ). In the thrombi, fibrin was also detected, and fibrin positivity was found at the sites of platelets with GP IIb/IIIa and P-selectin positivity
Results of the morphometric analysis are shown in Figure 5 . The thrombus size, quantified as the thrombus surface area, was significantly greater in the high-RBC group than that in the intermediateand low-RBC groups (high vs. low, P , 0.0001; high vs. intermediate, P , 0.0001; intermediate vs. low, P , 0.0001). The percentage of P-selectin-positive platelets was significantly less in the high-RBC group than that in the low-RBC group (high vs. low, P , 0. 
Relation of erythrocyte component of thrombi to clinical and angiographic findings and biochemical analysis
The baseline patient characteristics are shown in Table 1 . No statistically significant differences were found among the three groups, except for smoking and serum high-density lipoprotein cholesterol levels. As shown in Angiographic findings are presented in Table 2 . The thrombi in the high-and intermediate-RBC groups were found more frequently in the right coronary artery. Moreover, the baseline angiogram revealed a higher rate of occlusion in the IRA (P ¼ 0.04) and higher TIMI thrombus score (P ¼ 0.006) in the high-RBC group. Per cent stenosis after thrombus aspiration was significantly smaller in the high-RBC group than that in the intermediate-and low-RBC groups (P , 0.0001). Angiographic details showed a larger reference vessel diameter (P , 0.0001) and a larger stent size (P , 0.0001) in the high-RBC group, but more patients in the high-RBC group had thrombectomy only or balloon angioplasty after thrombectomy (P ¼ 0.0089). Angiographic visible distal embolization and myocardial no-reflow after PCI was seen more frequently in the high-RBC group than in the low-RBC group (distal embolization, P ¼ 0.0009; myocardial no-reflow, P ¼ 0.06), and more patients in the high-RBC group also required the use of an intra-aortic balloon pump for cardiogenic shock or slow flow/no reflow (P ¼ 0.0021).
Multivariate analysis revealed that smoking, higher TIMI thrombus score, and reference vessel diameter were independent factors associated with the erythrocyte-rich thrombus [ Cardiac function and remodelling at 6 months after STEMI are shown in Figure 7B . Angiographic follow-up at 6 months was accomplished in 155 patients (87%), and we could not perform angiographic follow-up at 6 months in 23 patients (13%). Of these 23 patients, 6 died in hospital [cardiac rupture, 1; congestive heart failure (CHF), 4; arrhythmias, 1] and 3 died after discharge during the 6-month follow-up because of pneumonia, aortic dissection, or sudden death. During the 6-month follow-up after discharge, CHF occurred in four patients, STEMI occurred in one patient and unstable angina pectoris occurred in one patient. Of the remaining eight patients, three were hospitalized elsewhere due to stroke and non-cardiovascular causes (pneumonia, two) at the time of 6 months, three did not undergo follow-up angiography due to advancing renal insufficiency (serum creatinine levels .2.0 mg/dL), and two refused the follow-up angiography due to advanced age. Restenosis occurred in 39 of the 155 patients (25%). There were no significant differences in restenosis rates among the three groups. The LVEF on admission and at 6 months were not significantly different among the three groups. However, the percentage increase in the LVEDVI were 
Discussion
To the best of our knowledge, the present study, analysing frozen sections of aspirated thrombi and using immunohistochemical staining for a protein specific to RBC membranes (glycophorin-A), is the first study to pathologically demonstrate the significance of the erythrocyte component of aspirated thrombi in STEMI patients. In the past few decades, several histopathological studies have revealed that coronary arterial thrombi are composed of platelets, fibrin, and usually erythrocytes and leucocytes. 8, 9 However, until now, the significance of the erythrocyte component has not been noted because a number of post-mortem studies could not provide accurate assessment of the difference Several reports have provided explanations for the mechanism of thrombosis. 8 -10 In the initial stage, platelets aggregate at the site of plaque disruption. As platelet aggregation continues, the thrombus grows with an increase in the fibrin component, and a loose network of fibrin may trap large numbers of erythrocytes. Previous pathological studies have shown that, after the thrombus at the disrupted plaque site leads to total luminal occlusion, blood immediately proximal and distal to the occlusion stagnates and coagulates, forming an erythrocyte-rich thrombus. 9 A previous clinical study also demonstrated that both a platelet-rich thrombus and an erythrocyte-rich thrombus are directly visualized by angioscopy in patients with unstable angina. 11 In this study, we clearly demonstrated that aspirated thrombi in STEMI patients can be divided into three types, low-RBC group (platelet-rich thrombi), intermediate-RBC group, and high-RBC group (erythrocyte-rich thrombi), despite the fact that all of our patients underwent PCI within 12 h of symptom onset and the reperfusion time from symptom onset was similar among the three groups. These findings are of considerable interest, since one could argue that some factors influencing blood properties and RBC aggregability may play a role in the evolution of erythrocyte-rich thrombi.
The main finding of this study is that the presence of MPOpositive cells in thrombi specimens and the plasma MPO and ox-LDL levels were increased in patients with erythrocyte-rich thrombi. Previously, we reported that the vast majority of MPOpositive cells were neutrophils, whereas only occasional MPOpositive cells were macrophages based on double-immunostaining techniques. 5 Additionally, a recent study by Ferrante et al. 12 Medications on admission Antiplatelets, n (%) 10 (17) 11 (19) 20 (34) 0.052 ACE inhibitors/ARB, n (%)
13 (22) 14 (24) 15 (25) 0.89
Beta-blockers, n (%) 4 (7) 7 (12) 3 (5) 0.36
Lipid-lowering agents, n (%) 4 (7) 10 (17) 6 (10) with ruptures. However, those study populations included sudden coronary death victims or non-STEMI patients, who were different from our cohort. Therefore, we could not make a direct comparison between those previous studies and our present study, and could not provide an explanation about the relationship between coronary plaque morphology and thrombus characterization. In this study, multivariate analysis demonstrated that smoking is an independent factor associated with the erythrocyte-rich thrombus. Baskurt et al. 15 reported that activated neutrophils can induce alterations of RBC properties, which result in hyper-aggregability, via oxygen-free radicals. Moreover, previous studies have shown that long-term smoking increases neutrophil counts, which have higher levels of MPO, in the circulation and increases RBC aggregability, resulting in higher blood viscosity. 16 Hence, these findings suggest that activated neutrophils, which may induce release of MPO into the blood stream and contribute to the oxidation of LDL, may have an effect on RBC aggregability, which could lead to formation of erythrocyte-rich thrombi. Our results also indicate the possibility that smoking plays a role in activation of neutrophils and in progression of RBC aggregation. Recent reports have presented results of histopathological evaluation of aspirated intracoronary thrombi obtained from STEMI patients. 17, 18 Moreover, Kramer et al. 17 showed the relationship between the presence of an older thrombus, which was histopathologically classified, and poor clinical outcome in STEMI patients treated with thrombus aspiration. However, these studies were based on thrombus materials fixed in formalin, and platelets and fibrin were not evaluated by using Figure 6 Graphs showing plasma myeloperoxidase and ox-low-density lipoprotein levels in patients with low-, intermediate-, and high-red blood cell components of thrombi and showing a relationship between log-transformed myeloperoxidase and ox-low-density lipoprotein levels in ST-elevation myocardial infarction patients.
Erythrocyte-rich thrombus in STEMI immunohistochemical methods with specific antibodies. Our study was based on frozen thrombus samples, because monoclonal antibodies against GP IIb/IIIa and P-selectin work well on frozen sections only, and we demonstrated for the first time a close relationship between erythrocyte-rich thrombi and poor electrocardiographic and angiographic myocardial reperfusion in STEMI patients. Microvascular obstruction is a multifactorial phenomenon (distal embolization, ischaemia-related injury, reperfusion-related injury, and individual susceptibility to microvascular injury etc), 19 but our present results may help to explain the possible mechanism responsible for impaired myocardial reperfusion associated with an erythrocyte-rich thrombus. Our angiographic and morphometric analyses showed that thrombus size in the high-RBC group was significantly greater than that in the low-RBC group. There is accumulating evidence that high thrombus burden is associated with distal embolization, which is known to affect myocardial reperfusion and prognosis. 20 Fokkema et al. 20 showed that thrombi aspirated in patients with distal embolization were larger and contained more erythrocytes than thrombi aspirated in patients without distal embolization. These findings support our results of positive associations between erythrocyte-rich component, thrombus size, and impaired myocardial reperfusion in STEMI patients. There are several other possible mechanisms underlying impaired myocardial reperfusion after PCI. Arakawa et al. 18 demonstrated that high neutrophil density in an aspirated thrombus is associated with impaired coronary microcirculation and LV dysfunction. Indeed, activated neutrophils, a major source of oxygen radicals, have been shown to play an increase in tissue factor activity and cause the occurrence of microvascular damage and cardiac reperfusion injury. 18 Thus, neutrophil activation is one of the major determinants of vascular impairment in reperfused hearts and MPO is just a marker of neutrophil activation. In fact, our and other recent data clinically showed that plasma MPO levels were associated with no-reflow phenomenon or impaired myocardial microcirculation in STEMI patients. 3, 21 These findings support the present results showing that the signs of impaired myocardial reperfusion were frequently observed in STEMI patients with erythrocyte-rich thrombi, which contained more MPO-positive cells. Pathophysiological explanations for our findings remain speculative; however, our data suggest that interaction among thrombus size, components and systemic, and/or local factors that influence thrombus characteristics could be associated with clinical outcomes in STEMI patients treated with thrombus aspiration.
Study limitation
There were several study limitations. First, our patients were not randomized, the number of patients was small and there was a certain degree of patient selection bias. Second, we were unable to determine whether retrieval of the thrombus was complete. This was due to difficulties associated with determining the actual amount of thrombus present in the vessel and the use of coronary angiography to determine whether retrieval of the thrombus was complete. Additionally, because the thrombus retrieval was done by aspiration through the catheter lumen and potential distortion of the samples might have occurred, we could not evaluate whether the thrombus we analysed was head or tail and surface or centre. If only part of the thrombus was aspirated, there is a possibility that the thrombus was misclassified; therefore, a sampling bias must be considered in studies based on the examination of these specimens. Third, this study lacked a contemporary assessment of plaque morphology by ultrasound or optical coherence tomography (OCT) to assess the relationship between thrombus characterization and plaque morphology. Future studies should confirm an association between the two by ultrasound or OCT. Fourth, our study clearly showed significant positive correlation between erythrocyte component and the counts of MPO-positive cells in the thrombi; however, we could detect small quantity of statistical outliers. When analysing using data of those outliers, the infiltration of MPO-positive cells in the thrombi seemed to be associated with leucocyte and neutrophil counts in the peripheral blood. These findings suggest that local accumulation of MPO-positive cells may be associated with not only thrombus size and component, but also systemic inflammatory status. Fifth, these data do not explain whether increased oxidative stress observed in patients with erythrocyte-rich thrombi is cause or effect. Because mechanism of thrombosis is Erythrocyte-rich thrombus in STEMI dynamic process that involves the interaction of many factors, the pathophysiological mechanisms require further investigation. Finally, we did not perform cardiac magnetic resonance imaging (MRI) for the evaluation of microvascular obstruction. Cardiac MRI can provide a more direct assessment of myocardial perfusion, therefore this parameter may need to be measured to improve test reliability and to evaluate the impact of erythrocyte-rich thrombi on myocardial perfusion.
Conclusion
The present study demonstrated that elevations in specific inflammatory and oxidative stress markers, such as MPO and ox-LDL, were observed in patients with erythrocyte-rich thrombi. Moreover, erythrocyte-rich thrombi contained more inflammatory cells and reflected high thrombus burden, resulting in impaired electrocardiographic and angiographic myocardial reperfusion and progression of LV remodelling.
